Literature DB >> 8622156

Long-term outcome after operation for trigeminal neuralgia in patients with posterior fossa tumors.

F G Barker1, P J Jannetta, R P Babu, S Pomonis, D J Bissonette, H D Jho.   

Abstract

During a 20-year period, 26 patients with typical symptoms of trigeminal neuralgia were found to have posterior fossa tumors at operation. These cases included 14 meningiomas, eight acoustic neurinomas, two epidermoid tumors, one angiolipoma, and one ependymoma. The median patient age was 60 years and 69% of the patients were women. Sixty-five percent of the symptoms were left sided. The median preoperative duration of symptoms was 5 years. The distribution of pain among the three divisions of the trigeminal nerve was similar to that found in patients with trigeminal neuralgia who did not have tumors; however, more divisions tended to be involved in the tumor patients. The mean postoperative follow-up period was 9 years. At operation, the root entry zone of the trigeminal nerve was examined for vascular cross-compression in 21 patients. Vessels compressing the nerve at the root entry zone were observed in all patients examined. Postoperative pain relief was frequent and long lasting. Using Kaplan-Meier methods the authors estimated excellent relief in 81% of the patients 10 years postoperatively, with partial relief in an additional 4%.

Entities:  

Mesh:

Year:  1996        PMID: 8622156     DOI: 10.3171/jns.1996.84.5.0818

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  [Vascular anomalies of the cerebellopontine angle].

Authors:  P Papanagiotou; I Q Grunwald; M Politi; T Struffert; F Ahlhelm; W Reith
Journal:  Radiologe       Date:  2006-03       Impact factor: 0.635

2.  Radiosurgery vs. microsurgery for newly diagnosed, small petroclival meningiomas with trigeminal neuralgia.

Authors:  Hun Ho Park; Woo Hyun Kim; Hyun-Ho Jung; Jong Hee Chang; Kyu-Sung Lee; Won Seok Chang; Chang-Ki Hong
Journal:  Neurosurg Rev       Date:  2020-07-08       Impact factor: 3.042

3.  Epidermoid tumors in the cerebellopontine angle presenting with trigeminal neuralgia.

Authors:  Dong Wuk Son; Chang Hwa Choi; Seung Heon Cha
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

4.  Neuroanatomical Determinants of Secondary Trigeminal Neuralgia: Application of 7T Ultra-High-Field Multimodal Magnetic Resonance Imaging.

Authors:  Annie E Arrighi-Allisan; Bradley N Delman; John W Rutland; Amy Yao; Judy Alper; Kuang-Han Huang; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2019-11-29       Impact factor: 2.104

5.  Surgical Resection of Cerebellopontine Epidermoid Cysts: Limitations and Outcome.

Authors:  Ahmed Farhoud; Wael Khedr; Hisham Aboul-Enein
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-23

6.  Trigeminal neuralgia as initial symptom of paramedian tentorial meningioma.

Authors:  Paolo Perrini; Fabrizio Rasile; James Leggate
Journal:  Neurol Sci       Date:  2009-01-24       Impact factor: 3.307

7.  Case Report: Trigeminal Neuralgia Caused by a Minute Meningioma with Hyperostosed Suprameatal Tubercle.

Authors:  Yukitomo Ishi; Katsuyuki Asaoka; Taku Sugiyama; Yuka Yokoyama; Kazuyoshi Yamazaki; Sumire Echizenya; Koji Itamoto; Kohei Echizenya
Journal:  Case Rep Neurol       Date:  2015-08-08

8.  Two Cases of Secondary Hemifacial Spasm: Pathophysiology and Management.

Authors:  Frederick A Zeiler; Anthony M Kaufmann
Journal:  J Mov Disord       Date:  2015-05-31

9.  Gamma knife radiosurgery for cerebellopontine angle epidermoid tumors.

Authors:  Amr M N El-Shehaby; Wael A Reda; Khaled M Abdel Karim; Reem M Emad Eldin; Ahmed M Nabeel
Journal:  Surg Neurol Int       Date:  2017-10-24

10.  A Case of Trigeminal Neuralgia Due to Cerebellopontine Epidermoid Cyst: Discrepancy between Intraoperative and Radiological Findings of Constructive Interference in Steady State (CISS).

Authors:  Masahito Katsuki; Norio Narita; Iori Yasuda; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.